Stock BEXIMCO PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Beximco Pharmaceuticals Limited Dhaka S.E.

Equities

End-of-day quote Dhaka S.E.
Other stock markets
- BDT - Intraday chart for Beximco Pharmaceuticals Limited
04-30 EARNINGS AND TRADING: Software Circle & Beximco report higher revenue AN
04-30 Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
EARNINGS AND TRADING: Software Circle & Beximco report higher revenue
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
CI
Beximco Pharmaceuticals to strengthen portfolio as interim profit up
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 30, 2023
CI
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Ex-dividend day for final dividend
FA
Beximco Pharmaceuticals Posts Higher Fiscal Q1 Profit, Revenue
MT
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023
CI
Beximco boosts revenue in local currency but profit falls
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Beximco Pharmaceuticals Limited Proposes Dividend for the Year Ended June 30, 2023
CI
Beximco Pharmaceuticals to Tackle Ophthalmic Manufacturing Unit Deficiencies After Malta Medicines Authority Audit
MT
EARNINGS UPDATES: HC Slingsby profit falls, East Imperial loss narrows
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
CI
TRADING UPDATES: Ferro-Alloy eyes revenue to drop below market view
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
CI
Beximco Pharmaceuticals Limited Announces Cash Dividend for the Year Ended June 30, 2022
CI
Ex-dividend day for final dividend
FA
EARNINGS SUMMARY: Goodbody shifts away from Covid; Beximco profit down
AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BXPHARMA Stock
  4. Stock
  5. News Beximco Pharmaceuticals Limited
  6. Highlights